Biodefense Market size is expected to reach US$ 21.67 Bn. by year 2029 at a CAGR of 6% during the forecast period.Biodefense Market Introduction
Biodefense is defined as the use of medical treatments, such as medicines and vaccines, to protect humans from bioterrorism. In addition, there has been progress in terms of research and public health preparedness to counter biological attacks. Synthetic biology is gaining popularity, mostly for the purpose of utilizing biological organisms to lower disease burdens and improve agricultural outputs.To know about the Research Methodology :- Request Free Sample Report
Biodefense Market Dynamics
Factors such as the availability of favorable government initiatives, increased government expenditure in developed nations, and rapid technical developments drive the biodefense market. Every year, governments invest a significant amount of money in vaccine research and development in order to be ready for potential bioterrorism strikes. Because governments choose to be prepared for any form of bioterrorism, pharmaceutical companies in the biodefense industry have a lot more potential. Several institutes in emerging markets, such as India's Defense Research and Development Organization (DRDO), are researching defensive measures to prevent biological assault. The military is putting forth a lot of effort to prepare for a biological strike. One of the major factors driving the need for biodefense is the steady increase in attention toward raising knowledge about bioterrorism across all nations, as well as many suggestions and meetings to combat such activity, which is one of the primary causes driving the demand for biodefense. In the last several decades, advances in genetic engineering and biotechnology have made it easier to manipulate these deadly and naturally existing viruses, which may now be re-engineered to cause much more harm. Furthermore, these organisms are readily available, making biodefense a critical element for governments all over the world. Anthrax, botulism, chemical and nuclear agents, as well as other biological agents, have all been employed as carriers for bioterrorism in the past, causing severe economic damage. As a result of these occurrences, the government has enacted biodefense legislation, treaties, and policies to combat biological threats, minimize risks, and prepare for respond to and recover from bio-incidents. By conducting continuous research to diagnose, treat, and prevent infectious diseases, whether deliberate or naturally occurring, the National Institute of Infectious Diseases has played a critical role in developing medical products and strategies to combat bioterrorism and emerging and re-emerging infectious diseases. The aforementioned factors, as well as the growing risk of infectious disease prevalence, are likely to propel the biodefense market forward.Biodefense Market Segment Analysis
In 2022, the anthrax segment dominated the biodefense market, accounting for 29.6% of total revenue. Over the projection period, the category is predicted to grow at a substantial CAGR of xx%. The biodefense market is divided into anthrax, smallpox, botulism, radiation/nuclear, and others, depending on the product. The anthrax bacteria is categorized as a category 1 biological agent by the National Center for Biotechnology Information because it is easily transmitted from one person to another and has the potential to have a significant public health impact. One of the areas where Project BioShield has invested heavily in vaccine research is anti-anthrax countermeasures. Many firms are testing anthrax vaccines in clinical studies. In the biodefense market, the other product category is anticipated to grow at the fastest rate throughout the forecast period. Viruses such as viral hemorrhagic fever, brucellosis, cholera, influenza, plague, food poisoning, tularemia, Zika and Ebola are included in the other segment. Tularemia, which is extremely contagious and may be deadly, has evolved into a bioweapon. As a result of the recent increase in Zika and Ebola virus infections in several countries, many companies are competing to produce vaccinations. Bavarian Nordic's MVA-BN Filo vaccine protects against the two most frequent forms of viral hemorrhagic fever: Ebola and Marburg virus. The vaccine is currently undergoing phase 3 clinical trials, and the firm has partnered with the National Institute of Allergy and Infectious Diseases in the United States to do so.Biodefense Market Regional Insights
Over the forecast period, the North American region is expected to dominate the market. The National Research and Technology Council (NSTC), which is part of the Office of Science and Technology Policy in the United States organizes science and technology, and biosecurity is one of its subjects. To raise awareness, a dedicated website was created with the public, academic researchers, scientific societies, and the biotechnology and pharmaceutical sectors in mind. The increase in government funding in the United States is attributed to various initiatives, such as the BioShield Act, the Biomedical Advanced Research and Development Authority (BARDA), and the Joint Program Executive Office for Chemical and Biological Defense, in order to generate and stockpile sufficient vaccines to be used against anthrax. For example, the US Department of Health and Human Services stated in 2018 that as part of an emergency preparation strategy, it will spend more than USD 25 million on an anthrax antitoxin. The Coalition for Epidemic Preparedness Innovations (CEPI) announced in May 2018 that USD 25 million has been awarded to improve the research and production of Nipah virus vaccines (NiV). Major market participants including Profectus BioSciences Inc. and Emergent BioSolutions Inc. received this financing. Due to rising R&D spending, the market for biodefense in APAC is anticipated to grow at the fastest rate of xx% over the forecast period. In addition, the region's biodefense market is being driven by the growing importance of biodefense and the rising threat of hazardous biological elements causing emergencies. Australia and Japan are two of the region's most developed biodefense markets, with well-established vaccine production facilities in both nations.Global Biodefense Market Report Scope: Inquire before buying
Global Biodefense Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 14.42 Bn. Forecast Period 2023 to 2029 CAGR: 6% Market Size in 2029: US $ 21.67Bn. Segments Covered: by Product Anthrax Smallpox Botulism Radiation/nuclear Others Biodefense Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Biodefense Market Key Players are:
1. XOMA corporation 2. Altimmune Inc. 3. Emergent Biosolutions Inc. 4. Dynavax Technologies Corporation. 5. SIGA Technologies. 6. Elusys Therapeutics Inc. 7. Ichor Medical Systems. 8. Dynport Vaccine Company. 9. ClevelandBiolabs. 10.Bavarian Nordic. 11.Ology Bioservices. 12.Alnylam Pharmaceuticals Inc 13.ANP Technologies Inc 14.General Dynamics Corp. 15.GlaxoSmithKline Plc 16.Alexeter Technologies LLC Frequently Asked questions 1. What is the market size of the Global Biodefense Market in 2022? Ans. The market size Global Biodefense Market in 2022 was US$ 14.42 Billion. 2. What are the different segments of the Global Biodefense Market? Ans. The Global Biodefense Market is divided into Product. 3. What is the study period of this market? Ans. The Global Biodefense Market will be studied from 2022 to 2029. 4. Which region is expected to hold the highest Global Biodefense Market share? Ans. The Asia Pacific dominates the market share in the market. 5. What is the Forecast Period of Global Biodefense Market? Ans. The Forecast Period of the market is 2023-2029 in the market.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Biodefense Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Global Biodefense Market 3.4. Geographical Snapshot of the Global Biodefense Market, By Manufacturer share 4. Global Biodefense Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Biodefense Market 5. Supply Side and Demand Side Indicators 6. Global Biodefense Market Analysis and Forecast, 2022-2029 6.1. Global Biodefense Market Size & Y-o-Y Growth Analysis. 7. Global Biodefense Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 7.1.1. Anthrax 7.1.2. Smallpox 7.1.3. Botulism 7.1.4. Radiation/nuclear 7.1.5. Others 8. Global Biodefense Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Global Biodefense Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 9.1.1. Nuclear Propulsion Systems 9.1.2. Diesel-electric Propulsion Systems 9.1.3. Air Independent Propulsion Systems 10. North America Global Biodefense Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Global Biodefense Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 12. Canada Global Biodefense Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 13. Mexico Global Biodefense Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 14. Europe Global Biodefense Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 15. Europe Global Biodefense Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Global Biodefense Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 17. France Global Biodefense Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 18. Germany Global Biodefense Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 19. Italy Global Biodefense Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 20. Spain Global Biodefense Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 21. Sweden Global Biodefense Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 22. CIS Countries Global Biodefense Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 23. Rest of Europe Global Biodefense Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 24. Asia Pacific Global Biodefense Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 25. Asia Pacific Global Biodefense Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Global Biodefense Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 27. India Global Biodefense Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 28. Japan Global Biodefense Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 29. South Korea Global Biodefense Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 30. Australia Global Biodefense Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 31. ASEAN Global Biodefense Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 32. Rest of Asia Pacific Global Biodefense Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 33. Middle East Africa Global Biodefense Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 34. Middle East Africa Global Biodefense Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Global Biodefense Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 36. GCC Countries Global Biodefense Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 37. Egypt Global Biodefense Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 38. Nigeria Global Biodefense Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 39. Rest of ME&A Global Biodefense Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 40. South America Global Biodefense Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 41. South America Global Biodefense Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Global Biodefense Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 43. Argentina Global Biodefense Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 44. Rest of South America Global Biodefense Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Biodefense Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1 XOMA Corporation 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Altimmune Inc. 45.3.3. Emergent Biosolutions Inc. 45.3.4. Dynavax Technologies Corporation. 45.3.5. SIGA Technologies. 45.3.6. Elusys Therapeutics Inc. 45.3.7. Ichor Medical Systems. 45.3.8. Dynport Vaccine Company. 45.3.9. ClevelandBiolabs. 45.3.10. Bavarian Nordic. 45.3.11. Ology Bioservices. 45.3.12. Alnylam Pharmaceuticals Inc 45.3.13. ANP Technologies Inc 45.3.14. General Dynamics Corp. 45.3.15. GlaxoSmithKline Plc 45.3.16. Alexeter Technologies LLC 45.3.17. Other Key players